Application 019487
- Type
- NDA
- Sponsor
- J AND J CONSUMER INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IMODIUM A-D | LOPERAMIDE HYDROCHLORIDE | SOLUTION;ORAL | 1MG/5ML | Yes | Yes |
| 002 | IMODIUM A-D | LOPERAMIDE HYDROCHLORIDE | SUSPENSION;ORAL | 1MG/7.5ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019487-001 | IMODIUM A-D | LOPERAMIDE HYDROCHLORIDE | 1MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 1988-03-01 | |
| N019487-002 | IMODIUM A-D | LOPERAMIDE HYDROCHLORIDE | 1MG/7.5ML | SOLUTION / ORAL | RLD, RS | 2004-07-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N019487-001 | IMODIUM A-D | 1MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 1988-03-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SOLUTION / ORAL | RLD, RS | 2004-07-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N019487-001 | IMODIUM A-D | 1MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 1988-03-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SOLUTION / ORAL | RLD, RS | 2004-07-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD | 1988-03-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SOLUTION / ORAL | RLD, RS | 2004-07-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD | 1988-03-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SOLUTION / ORAL | RLD, RS | 2004-07-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD | 1988-03-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019487-001 | IMODIUM A-D | 1MG/5ML | SOLUTION / ORAL | RLD, RS | 1988-03-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019487-002 | IMODIUM A-D | 1MG/7.5ML | SUSPENSION / ORAL | RLD, RS | 2004-07-08 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Imodium A-D | LOPERAMIDE HYDROCHLORIDE | Kenvue Brands LLC | 76a976d5-8bee-4158-a94d-7fbfc5544fd4 | 2025-09-23 | Warnings | 019487 NDA019487 50580-134 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50580-134 | Imodium | Loperamide Hydrochloride | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | NDA | Current |
| 50580-134 | Imodium | Loperamide Hydrochloride | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | NDA | Current |
| 50580-134 | Imodium | Loperamide Hydrochloride | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 59669 | SUPPL | 2019-08-13 |
| 59668 | SUPPL | 2019-08-12 |
| 48028 | SUPPL | 2017-04-14 |
| 48020 | SUPPL | 2017-04-14 |
| 11512 | SUPPL | 2016-04-11 |
| 1341 | SUPPL | 2016-04-07 |
| 11511 | SUPPL | 2015-03-24 |
| 17418 | SUPPL | 2015-03-19 |
| 20250 | SUPPL | 2008-07-31 |
| 40913 | SUPPL | 2008-07-30 |
| 20249 | SUPPL | 2008-04-04 |
| 1340 | SUPPL | 2005-06-09 |
| 1339 | SUPPL | 2004-07-14 |
| 17417 | SUPPL | 2004-06-16 |